“…Of the seven mammalian homologues of Sir2 that include SIRT1 through SIRT7, SIRT1 plays a significant role in oxidative stress, cell metabolism, genomic stability, cell survival, neurodegenerative disease, infection, and cardiovascular disease [102–107]. In regards to cytoprotection, SIRT1 activation can prevent hypoxic injury in retinal ganglion cells [108], modulate cell longevity [109, 110], protect against high-fat diet-induced metabolic abnormalities [111, 112], increase cellular survival during anoxia and ischemia [113, 114], reduce Aβ toxicity [115], reverse impaired fat and glucose metabolism [12, 116–118], maintain mitochondrial processing and quality through autophagy [119], foster cellular protection against radiation [120], protect against renal cell aging [121], block apoptotic pathways in preadipocytes [122], and modulate forkhead mediated apoptotic pathways [53, 72, 96, 118, 123–126]. Yet, other studies suggest that to achieve cytoprotection through sirtuin pathways, the level of sirtuin activity may be critical [53, 72, 115, 127], since SIRT1 gene polymorphisms may affect protein expression during cardiovascular disease [105], SIRT1 activity can promote tumor growth [128, 129], and reduction in SIRT1 activity has been reported to enhance the cytoprotective effects of IGF-1 [130].…”